Daré Bioscience, Inc.DARENASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank86
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-6.10M
↑ 64% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-17.13M
Historical baseline
PeriodValueYoY Change
TTM$-6.10M-213.1%
2024$5.39M+113.9%
2023$-38.86M-114.8%
2022$-18.09M+37.1%
2021$-28.76M-14.0%
2020$-25.23M-89.5%
2019$-13.32M-29.7%
2018$-10.27M-304.2%
2017$-2.54M+92.4%
2016$-33.54M-